Remote Monitoring

Remote cardiac monitoring technologies enable patient health to be tracked outside the clinical setting. It can be used for longer term monitoring to help diagnosis arrhythmias or other cardiac conditions. Remote monitoring also can keep tabs on chronic conditions such as heart failure or hypertension and alert clinicians to worsening symptoms to avoid an acute care episode or hospitalization.

RSS icon
Video interview with ACC President Cathie Biga on goals for college over the next year and trends she saw at ACC 2024.

New ACC President Cathie Biga wants to improve quality reporting in cardiology

Biga, who originally trained as a nurse, specializes in the business side of cardiology. She also emphasized the increasing importance of AI and other new technologies. 

The HeartBeam AIMIGo device is approximately the size of a credit card and uses the company’s patented 3D vectorelectrocardiography (3D VECG) technology to capture signals from three different projections and deliver a synthesized 12-lead ECG.

New research underway on credit card-sized heart monitor that synthesizes 12-lead ECGs

The portable device uses HeartBeam's patented 3D vectorelectrocardiography (3D VECG) technology to capture signals from three different projections and deliver a synthetic 12-lead ECG.

Dexcom, a global healthcare technology company based out of San Diego, has received U.S. Food and Drug Administration (FDA) clearance for Stelo, a wearable glucose biosensor that can be obtained without a prescription.

FDA clears first over-the-counter wearable device for continuous glucose monitoring

The newly cleared device is worn on the back of the arm and sends data directly to the user's smartphone. 

Left, the FIRE1 heart failure remote monitoring device that gets implanted into the IVC to measure fluid volume status. Right, the external belt monitoring device worn by the patient that can alert clinicians about status changes so interventions can be done before a patient requires a hospital admission. 

Early feasibility study for implantable heart failure monitor moves forward 

Startup vendor FIRE1 completed patient enrollment in its U.S. early feasibility study for a heart failure remote monitoring device that directly measures fluid volume inside the IVC.

Thumbnail

FDA warns against use of unauthorized smartwatch, smart ring devices to measure blood glucose levels

Any devices that claim to make blood glucose measurements without piercing the user's skin are associated with a heightened risk of error, the agency said. 

Multiple factors can interfere with pulse oximetry accuracy including skin pigmentation. Multiple studies have shown the inaccuracy of current pulse oximeters in patients with darker skin tones than whites, often over estimating their oxygenation when in fact they are hypoxic. Images courtesy of Masimo.

Inaccurate pulse oximeter readings impact Black heart failure patients and FDA plans to address this

Black patients are already less likely to receive LVADs or transplants compared to whites, and these inaccurate readings can further widen the disparities.

money business cash flow dollar

Medical device company raises $136M to continue work on new 2-in-1 heart failure technology

New Jersey-based Impulse Dynamics says it will use the new financing to fund clinical research and continue developing advanced heart failure devices. 

Medtronic shared new STROKE AF data on the Reveal Linq ICM

Medtronic ICM a cost-effective approach for reducing the risk of ischemic stroke

Remote monitoring with the Reveal Linq insertable cardiac monitor can improve outcomes without breaking the bank, according to new data being presented at the International Stroke Conference in Phoenix.

Displaying 33 - 40 of 132

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.